Table 1 Significant demographic, medical, and behavioral predictors of adherence to supervised exercise in the CARE Trial, 2008–2011, Canada

Group assignment

-.13; 0.025

3.1; 0.048

 Standard aerobic (n = 96)

78% ± 24%

 Combined (n = 104)

71% ± 23%

 High aerobic (n = 101)

70% ± 25%

Location/Center

.42; <0.001

37.8; <0.001

 Ottawa (n = 84)

63% ± 27%

 Edmonton (n = 117)

68% ± 23%

 Vancouver (n = 100)

88% ± 13%

Baseline Aerobic Exercise

.14; 0.015

5.1; 0.024

 Not meeting guidelines (n = 210)

71% ± 25%

 Meeting guidelines (n = 91)

78% ± 21%

Exercise limitations

-.10; 0.098

5.8; 0.017

 Not at all/a little (n = 150)

76% ± 22%

 Somewhat/a lot/completely (n = 151)

70% ± 26%

Comorbidities

-.04; 0.54

4.0; 0.047

 0 (n = 135)

76% ± 23%

 ≥1 (n = 166)

70% ± 24%

Length of chemotherapy protocol

-.13; 0.031

4.7; 0.031

 12 weeks (n = 89)

78% ± 21%

 ≥18 weeks (n = 212)

71% ± 25%

FEC-D³

-.14; 0.013

6.2; 0.013

 No (n = 200)

75% ± 22%

 Yes (n = 101)

68% ± 27%